SCHEMBL5503708

SCHEMBL5503708

O=S(O)C(F)(F)CCNCC1CCCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 6/20 0.37
MLYCD O95822 1/20 0.37
ADH1B P00325 1/20 0.36
ADH1C P00326 1/20 0.36
ADH1A P07327 1/20 0.36
ADH4 P08319 1/20 0.36
ADH7 P40394 1/20 0.36
HDAC4 P56524 4/20 0.33
EPHX1 P07099 4/20 0.33
HDAC3 O15379 3/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC9 Q9UKV0 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6008738 0.98 HDAC6 (0.39) HDAC6MLYCDADH1BADH1CADH1A
SCHEMBL6009983 0.77 RAD52 (0.38) EPHX1KDM4EALDH1A1KMT2A
SCHEMBL6009446 0.76 RAD52 (0.40) EPHX1KDM4E
SCHEMBL5504891 0.71 HDAC6 (0.39) HDAC6MLYCDADH1BADH1CADH1A
SCHEMBL19700576 0.70 SAT1 (0.41) HDAC6MLYCDADH1BADH1CADH1A
SCHEMBL5503734 0.69 ADH1B (0.36) HDAC6MLYCDADH1BADH1CADH1A
SCHEMBL23794486 0.69 SAT1 (0.43) HDAC6MLYCDSAT1
SCHEMBL8048307 0.68 ADH1B (0.42) HDAC6MLYCDADH1BADH1CADH1A
SCHEMBL5505547 0.68 ADH1B (0.39) HDAC6MLYCDADH1BADH1CADH1A
SCHEMBL11594234 0.68 ADH1B (0.54) HDAC6ADH1BADH1CADH1AADH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828111-A2 METHODS AND FLUORINATED COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES Neurochem (International) Limited (CH) 2007-09-05 EP disclosed
US-20060183800-A1 Methods and fluorinated compositions for treating amyloid-related diseases BELLUS HEALTH (INTERNATIONAL) LIMITED (CH) 2006-08-17 US disclosed
WO-2006059252-A2 METHODS AND FLUORINATED COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2006-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060183800-A1 Methods and fluorinated compositions for treating amyloid-related diseases APP, PSEN1, TTR HDAC6 2174/4885MLYCD 2022/4885ADH1B 1226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.